ALB vs SLS · rev $1.74B vs $1.62B cap
Albemarle Corp (ALB) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
ALB currently screens at market cap $8.00B. SLS currently screens at market cap $1.62B.
Not investment advice. Open the ALB and SLS stock pages for the full models.
Not investment advice.